The amended authorization is for children six months through four years of age who have completed their initial three-dose vaccination with Pfizer’s original shot.
https://www.pharmalive.com/wp-content/uploads/2023/03/Pfizer-syringe.jpg7201080Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-03-14 19:15:462023-03-15 09:47:04U.S. FDA expands authorization of Pfizer bivalent COVID-19 shots in kids
